Weigao Orthopedics (688161.SH) distributed 0.05 yuan per share in the third quarter, with a record date of December 11th.

Weigao Orthopedics (688161.SH) announced that the company will implement the distribution of earnings for the third quarter of 2024, with... per share...

Zhitong FinanceDec 5 16:59

Weigao Orthopedics (688161): Revenue and profits have fully recovered with growth, and performance restoration exceeds expectations.

Key points: The performance growth rate in the third quarter of 2024 exceeded expectations. The company achieved revenue of 1.083 billion yuan in the first three quarters, a year-on-year increase of 0.07%; net income attributable to shareholders of listed companies was 0.164 billion yuan, a year-on-year increase of 34.

Guosen SecuritiesNov 22 20:17

Weigao Orthopedic: Shandong Weigao Orthopedic Materials Co., Ltd. Report for the third quarter of 2024

SZSIOct 31 00:00 · Announcements

Shandong Weigao Orthopedic Materials Co., Ltd. Report for the third quarter of 2024

SZSIOct 31 00:00 · Announcements

Weigao Orthopedics (688161.SH) declared a semi-annual dividend of 0.7 yuan per 10 shares with a record date of October 24th.

Weigao Orthopedics (688161.SH) announced that the company will implement the distribution of equity for the first half of 2024, with a distribution of 1...

Zhitong FinanceOct 18 16:06

Weigao Orthopedics (688161): The impact of orthopedic group procurement is gradually being resolved, and Q3 is expected to usher in a turning point in performance.

The core view of the company is that it is a leading player in the domestic orthopedic industry with a comprehensive product line. The performance in the first half of the year is in line with expectations. Since 2022, the company's various product lines have been successively affected by the price reduction of centralized procurement; currently, joint, trauma, and spine, the three major areas of centralized procurement have all been implemented.

cscSep 18 18:11